tiprankstipranks
ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
US Market

ADC Therapeutics (ADCT) Income Statement

282 Followers

ADC Therapeutics Income Statement

Last quarter (Q4 2022), ADC Therapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, ADC Therapeutics's net income was $―. See ADC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 140.11M$ 69.56M$ 209.91M$ 33.92M$ 0.00$ 2.34M
Cost of Revenue
$ 4.09M$ 1.61M$ 4.58M$ 1.39M$ 0.00-
Gross Profit
$ 136.02M$ 66.53M$ 205.33M$ 32.52M$ 0.00-
Operating Expense
$ 248.91M$ 233.01M$ 328.96M$ 312.58M$ 219.26M$ 121.74M
Operating Income
$ -112.89M$ -165.99M$ -123.63M$ -280.06M$ -219.26M$ -119.40M
Net Non Operating Interest Income Expense
$ -10.78M$ -35.78M$ -18.95M$ 66.00K$ -4.09M$ 2.10M
Other Income Expense
$ -10.80M$ -1.32M$ 167.88M$ 201.54M$ -22.61M$ 1.40M
Pretax Income
$ -134.47M$ -195.42M$ -310.46M$ -481.53M$ -245.96M$ -115.90M
Tax Provision
$ -2.83M$ 39.11M$ 1.14M$ -21.48M$ 327.00K$ 582.00K
Earnings From Equity Interest Net Of Tax
-$ -5.53M----
Net Income Common Stockholders
$ -131.64M$ -240.05M$ -311.60M$ -460.05M$ -246.29M$ -116.48M
Basic EPS
$ -1.71$ -2.94$ -1.99$ -3.00$ -3.77$ -2.16
Diluted EPS
$ -1.71$ -2.94$ -1.99$ -3.00$ -3.77$ -2.16
Basic Average Shares
$ 232.11M$ 81.71M$ 78.15M$ 76.75M$ 65.41M$ 53.83M
Diluted Average Shares
$ 232.11M$ 81.71M$ 78.15M$ 76.75M$ 65.41M$ 53.83M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
$ -0.96---$ -2.69-
Reported Normalized Diluted E P S
$ -0.96---$ -2.69-
Rent Expense Supplemental
------
Total Expenses
$ 253.00M$ 234.62M$ 333.54M$ 313.98M$ 219.26M$ 121.74M
Net Income From Continuing And Discontinued Operation
$ -131.64M$ -240.05M$ -311.60M$ -460.05M$ -246.29M$ -116.48M
Normalized Income
$ -114.82M$ -154.38M--$ -205.79M$ -116.27M
Interest Expense
$ 29.37M---$ 4.93M$ 156.00K
EBIT
$ -105.10M$ -149.09M$ -273.54M$ -481.53M$ -241.04M$ -115.75M
EBITDA
$ -103.34M$ -126.62M$ -273.42M$ -481.40M$ -238.85M$ -114.10M
Currency in USD

ADC Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis